Pharmacology of Potassium Channels

Advances in Pharmacology

Volumn 39, Issue C, 1997, Pages 425-471

  Garcia, Maria L ^a   Hanner, Markus ^a   Knaus, Hans Günther ^b   Koch, Robert ^b   Schmalhofer, William ^a   Slaughter, Robert S ^a   Kaczorowski, Gregory J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Institute for Biochemical Pharmacology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; SCORPION VENOM; SNAKE VENOM;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECT; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; POTASSIUM CHANNELS; SCORPION VENOMS; SEQUENCE HOMOLOGY, AMINO ACID; SNAKE VENOMS;

EID: 0030629190     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60078-2     Document Type: Article

References (188)

1. Adelman J.P., Shen K.-Z., Kavanaugh M.P., Warren R.A., Wu Y.-N., Lagrutta A., Bond C.T., and North R.A. Calcium-activated potassium channels expressed from cloned complementary DNAs. Neuron 9 (1992) 209-216
2. Aggarwal S.K., and MacKinnon R. Determination of Shaker K+ channel number and gating charge in individual Xenopus oocytes. Biophys. J. 66 (1994) A136
3. Aguilar-Bryan L., Nichols C.G., Wechsler S.W., Clement J.P., Boyd A.E., Gonzalez G., Herrera-Sosa H., Nguy K., Bryan J., and Nelson D.A. Cloning of the β cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science 268 (1995) 423-425
4. Aiyar J., Grissmer S., and Chandy K.G. The L401V mutation in Kv3.1 does not alter single channel conductance or K+/Rb+ selectivity. Biophys. J. 64 (1993) 197a
5. Aiyar J., Withka J.M., Rizzi J.P., Singleton D.H., Andrews G.C., Lin W., Boyd J., Hanson D.C., Simon M., Dethlefs B., Lee C.-L., Hall J.E., Gutman G.A., and Chandy K.G. Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins. Neuron 15 (1995) 1169-1181
6. Ämmälä C., Moorhouse A., Gribble F., Ashfield R., Proks P., Smith P.A., Sakura H., Coles B., Ashcroft S.J.H., and Ashcroft F.M. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels. Nature (London) 379 (1996) 545-548
7. Aneiros A., García I., Martínez J.R., Harvey A.L., Anderson A.J., Marshall D.L., Engström A., Hellman U., and Karlsson E. A potassium channel toxin from the secretion of the sea anemone Bunodosoma granulifera. Isolation, amino acid sequence and biological activity. Biochim. Biophys. Acta 1157 (1993) 86-92
8. Auguste P., Hughes M., and Lazdunski M. Polypeptide constitution of receptors for apamin, a neurotoxin which blocks a class of Ca2+-activated K+ channels. FEBS Lett. 248 (1989) 150-154
9. Auguste P., Hugues M., Gravé B., Gesquiere J.-C., Maes P., Tartar A., Romey G., Schweitz H., and Lazdunski M. Leiurotoxin I (Scyllatoxin), a peptide ligand for Ca2+-activated K+ channels. J. Biol. Chem. 265 (1990) 4753-4759
10. Auguste P., Hugues M., Mourre C., Moinier D., Tartar A., and Lazdunski M. Scyllatoxin, a blocker of Ca2+-activated K+ channels: Structure-function relationships and brain localization of the binding sites. Biochemistry 31 (1992) 648-654
11. Benishin C.G., Sorensen R.G., Brown W.E., Krueger B.K., and Blaustein M.P. Four polypeptide components of green mamba venom selectively block certain potassium channels in rat brain synaptosomes. Mol. Pharmacol. 34 (1988) 152-159
12. Berndt K.D., Güntert P., and Wüthrich K. Nuclear magnetic resonance solution structure of dendrotoxin K from venom of Dendroaspis polylepis polylepis. J. Mol. Biol. 234 (1993) 735-750
13. Bidard J.-N., Mourre C., and Lazdunski M. Two potent central convulsant peptides, a bee venom toxin, the MCD peptide and a snake venom toxin, dendrotoxin I, known to block K+ channels, have interacting receptors sites. Biochem. Biophys. Res. Commun. 143 (1987) 383-389
14. Blatz A.L., and Magleby K.L. Single apamin blocked Ca-activated K+ channels of small conductance in cultured rat skeletal muscle. Nature (London) 323 (1986) 718-720
15. Bontems F., Roumestand C., Boyot P., Gilquin B., Doljansky Y., Menez A., and Toma F. Three-dimensional structure of natural charybdotoxin in aquous solution by 1H-NMR. Charybdotoxin possesses a structural motif found in other scorpion toxins. Eur. J. Biochem. 196 (1991) 19-28
16. Bontems F., Roumestand C., Gilquin B., Menez A., and Toma F. Refined structure of charybdotoxin: Common motifs in scorpion toxins and insect defensins. Science 254 (1991) 1521-1523
17. Bowring N.E., Arch J.R.S., Buckle D.R., and Taylor J.F. Comparison of the airways relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea-pigs and rats. Br.J. Pharmacol. 109 (1993) 1133-1139
18. Breeze A.L., and Dolly J.O. Interactions between discrete neuronal membrane binding sites for the putative K+-channel ligands β-bungarotoxin, dendrotoxin and mast-cell-degranulating peptide. Eur. J. Biochem. 178 (1989) 771-778
19. Brugnara C., Armsby C.C., Franceschi L.D., Crest M., Euclaire M.-F.M., and Alper S.L. Ca2+-activated K+ channels of human and rabbit erythrocytes display distinctive patterns of inhibition by venom peptide toxins. J. Membr. Biol. 147 (1995) 71-82
20. Butler A., Tsunoda S., McCobb D.P., Wei A., and Salkoff L. mSlo, a complex mouse gene encoding "maxi" calcium-activated potassium channels. Science 261 (1993) 221-224
21. Byrnes M.E., Mahnir V.M., Kern W.R., and Pennington M.W. Synthesis and characterization of dendrotoxin: A potent potassium channel inhibitor. Protein Pept. Lett. 1 (1995) 239-245
22. Candia S., Garcia M.L., and Latorre R. Mode of action of iberiotoxin, a potent blocker of the large conductance Ca2+-activated K+ channel. Biophys. J. 63 (1992) 583-590
23. Carbone E., Wanke E., Prestipino G., Possani L.D., and Maelicke A. Selective blockage of voltage-dependent K+ channels by a novel scorpion toxin. Nature (London) 296 (1982) 90-91
24. Castañeda O., Sotolongo V., Amor A.M., Stöcklin R., Anderson A.J., Harvey A.L., Engström A., Wernstedt C., and Karlsson E. Characterization of a potassium channel toxin from the Caribbean sea anemone Stichodactyla helianthus. Toxicon 33 (1995) 603-613
25. Castellino R., Morales M.J., Strauss H.C., and Rasmusson R.L. Time- and voltage-dependent modulation of a Kv1.4 channel by a β-subunit (Kvβ3) cloned from ferret ventricle. Am. J. Physiol. 269 (1995) H385-H391
26. Chandy K.G., and Gutman G.A. In: North R.A. (Ed). Voltage-gated potassium channel genes "Ligand-and Voltage-gated Ion Channels" (1995), CRC Press, Boca Raton 1-71
27. Chicchi F.L.G.G., Gimenez-Gallego G., Ber E., Garcia M.L., Winquist R., and Cascieri M.A. Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus habraeus venom. J. Biol. Chem. 263 (1988) 10192-10197
28. Choi K.L., Mossman C., Aube J., and Yellen G. The internal quaternary ammonium receptor site of Shaker potassium channels. Neuron 10 (1993) 533-541
29. Colatsky T.J., and Argentieri T.M. Potassium channel blockers as antiarrhythmic drugs. Drug Dev. Res. 33 (1994) 235-249
30. Cook N.S., Haylett D.N., and Strong P. High affinity binding of 125I-monoiodo apamin to isolated guinea-pig hepatocytes. Febs Lett. 152 (1983) 265-269
31. Crest M., Jacquet G., Gola M., Zerrouk H., Benslimane A., Rochat H., Mansuelle P., and Martin-Eauclaire M.-F. Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca2+-activated K+ channels characterized from Androctonus mauretanicus tnaure-tanicus venom. J. Biol. Chem. 267 (1992) 1640-1647
32. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., and Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell (Cambridge, Mass.) 80 (1995) 795-803
33. Danse J.M., Rowan E.G., Gasparini S., Ducancel F., Vatanpour H., Young L.C., Poorheid-ari G., Lajeunesse E., Drevet P., Ménez R., Pinkasfeld S., Boulain J.-C., Harvey A.L., and Ménez A. On the site by which a-dendrotoxin binds to voltage-dependent potassium channels: Site-directed mutagenesis reveals that the lysine triplet 28-30 is not essential for binding. FEBS Lett. 356 (1994) 153-158
34. Dauplais M., Gilquin B., Possani L.D., Gurrola-Briones G., Roumestand C., and Menez A. Determination of the three-dimensional solution structure of noxiustoxin: Analysis of structural differences with related short-chain scorpion toxins. Biochemistry 34 (1995) 16563-16573
35. DeFarias F.P., Stevens S.P., and Leonard R.J. Stable expression of human Kv1.3 potassium channels resets the resting membrane potential of cultured mammalian cells. Recept. Channels 3 (1995) 273-281
36. Deutsch C., Price M., Lee S., King V.F., and Garcia M.L. Characterization of high affinity binding sites for charybdotoxin in human T lymphocytes: Evidence for association with the voltage-gated K+ channel. J. Biol. Chem. 266 (1991) 3668-3674
37. Docherty R.J., Dolly J.O., Halliwell J.V., and Othman I. Excitatory effects of dendrotoxin on the hippocampus in vitro. J. Physiol. (London) 336 (1983) 58-59
38. Dolly J.O., Halliwell J.V., Black J.D., Williams R.S., Pelchen-Matthews A., Breeze A., Mehraban F., Othman I.B., and Black A.R. Botulinum neurotoxin and dendrotoxin as probes for studies of neurotransmitter release. J. Physiol. (Paris) 79 (1984) 280-303
39. Drakopoulou E., Cotton J., Virelizier H., Bernardi E., Schoofs A.R., Partiseti M., Choquet D., Gurrola G., Possani L.D., and Vita C. Chemical synthesis, structural and functional characterization of noxiustoxin, a powerful blocker of lymphocyte voltage-dependent K+ channels. Biochem. Biophys. Res. Commun. 213 (1995) 901-907
40. Dworetzky S.I., Trojnacki J.T., and Gribkoff V.K. Cloning and expression of a human large-conductance calcium-activated potassium channel. Mol. Brain Res. 27 (1994) 189-193
41. Edwards G., and Weston A.H. Structure-activity relationship of K+ channel openers. Trends Pharmacol. Sci. 11 (1990) 417-422
42. Edwards G., and Weston A.H. The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol. 33 (1993) 597-637
43. Edwards G., and Weston A.H. Pharmacology of the potassium channel openers. Cardiovasc. Drugs Thera. 9 (1995) 185-193
44. England S.K., Uebele V.N., Kodali J., Bennett P.B., and Tamkun M.M. A novel K+ channel β-subunit (hKvβ1.3) is produced via alternative mRNA splicing. J. Biol. Chem. 270 (1995) 28531-28534
45. England S.K., Uebele V.N., Shear H., Kodali J., Bennett P.B., and Tamkun M.M. Characterization of a voltage-gated K+ channel β subunit expressed in human heart. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 6309-6313
46. Felix J.P., Bugianesi R.M., Abramsom A.A., and Slaughter R.S. Binding of mono-and di-iodinated margatoxin to human peripheral T lymphocytes and to Jurkat plasma membranes. Biophys. J. 68 (1995) 267a
47. Fernandez I., Romi R., Szendeffy S., Martin-Eauclaire M.R., Rochat H., Rietschoten J.B., Pons M., and Giralt E. Kaliotoxin (1-37) shows structural differences with related potassium channel blockers. Biochemistry 33 (1994) 14256-14263
48. Flinn J.P., Murphy R., Johns R.B., Kunze W.A.A., and Angus J.A. Synthesis and biological characterisation of a series of iberiotoxin analogues. Int. J. Pep. Protein Res. 45 (1995) 320-325
49. Foray M.-F., Lancelin J.-M., Hollecker M., and Marion D. Sequence-specific 1H-NMR assignment and secondary structure of black mamba dendrotoxin I, a highly selective blocker of voltage-gated potassium channels. Eur. J. Biochem. 211 (1993) 813-820
50. Galvez A., Gimenez-Gallego G., Reuben J.P., Roy-Contancin L., Feigenbaum P., Kaczorow-ski G.J., and Garcia M.L. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J. Biol. Chem. 265 (1990) 11083-11090
51. Garcia M.L., Garcia-Calvo M., Hidalgo P., Lee A., and MacKinnon R. Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom. Biochemistry 33 (1994) 6834-6839
52. Garcia-Calvo M., Leonard R.J., Novick J., Stevens S.P., Schmalhofer W., Kaczorowski G.J., and Garcia M.L. Purification, characterization and biosynthesis of marga-toxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J. Biol. Chem. 268 (1993) 18866-18874
53. Garcia-Calvo M., Knaus H.-G., McManus O.B., Giangiacomo K.M., Kaczorowski G.J., and Garcia M.L. Purification and reconstitution of the high-conductance calcium-activated potassium channel from tracheal smooth muscle. J. Biol. Chem. 269 (1994) 676-682
54. Gaspar R., Bene L., Damjanovich S., Munoz-Garay C., Calderon-Aranda E.S., and Possani L.D. β-Scorpion toxin 2 from Centruroides noxius blocks voltage-gated K+ channels in human lymphocytes. Biochem. Biophys. Res. Commun. 213 (1995) 419-423
55. Giangiacomo K.M., Garcia M.L., and McManus O.B. Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry 31 (1992) 6719-6727
56. Giangiacomo K.M., Sugg E.E., Garcia-Calvo M., Leonard R.J., McManus O.B., Kaczorowski G.J., and Garcia M.L. Synthetic charybdotoxin-iberiotoxinchimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels. Biochemistry 32 (1993) 2363-2370
57. Giangiacomo K.M., Garcia-Calvo M., Knaus H.-G., Mullmann T.J., Garcia M.L., and McManus O. Functional reconstitution of the large-conductance, calcium-activated potassium channel purified from bovine aortic smooth muscle. Biochemistry 34 (1995) 15849-15862
58. Gimenez-Gallego G., Navia M.A., Reuben J.P., Katz G.M., Kaczorowski G.J., and Garcia M.L. Purification, sequence and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 3329-3333
59. Goh J.W., Kelley M.E.M., Pennefather P.S., Chicchi G.G., Cascieri M.A., Garcia M.L., and Kaczorowski G.J. Effect of charybdotoxin and leiurotoxin I on potassium currents in bullfrog sympathetic ganglion and hippocampal neurons. Brain Res. 591 (1992) 165-170
60. Goldstein S.A.N., and Miller C. Mechanism of charybdotoxin block of a voltage-gated K+ channel. Biophys. J. 65 (1993) 1613-1619
61. Goldstein S.A.N., Pheasant D.J., and Miller C. The charybdotoxin receptor of a Shaker K+ channel: Peptide and channel residues mediating molecular recognition. Neuron 12 (1994) 1377-1388
62. Granier C., Pedroso-Muller E., and Rietschoten J.V. Use of synthetic analogs for a study on the structure-activity relationship of apamin. Eur. J. Biochem. 82 (1978) 293-299
63. Grissmer S., Nguyen A.N., Aiyar J., Hanson D.C., Mather R.J., Gutman G.A., Karmilowicz M.J., Auperin D.D., and Chandy K.G. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv 1.1, 1.2, 1.3, 1.5 and 3.1, stably expressed in mammalian cell lines. Mol. Pharmacol. 45 (1994) 1227-1234
64. Gross A., Abramson T., and MacKinnon R. Transfer of the scorpion toxin receptor to an insensitive potassium channel. Neuron 13 (1994) 961-966
65. Halliwell J.V., Othman I.B., Pelchen-Matthews A., and Dolly J.O. Central action of dendrotoxin: Selective reduction of a transient K conductance in hippocampus and binding to localized acceptors. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 493-497
66. Harvey A.L., and Anderson A. Dendrotoxins: Snake toxins that block potassium channels and facilitate neurotransmitter release. Pharmacol. Ther. 31 (1985) 33-55
67. Harvey A.L., and Karlsson E. Protein inhibitor homologues from Mamba venoms: Facilitation of acetylcholine release and interactions with prejunctional blocking toxins. Br. J. Pharmacol. 77 (1982) 153-161
68. Hidalgo P., and MacKinnon R. Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor. Science 268 (1995) 307-310
69. Hill R.J., Grant A.M., Volberg W., Rapp L., Faltynek C., Miller D., Pagani K., Baizman E., Wang S., Guiles J.W., and Krafte D.S. WIN 17317-3: Novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes. Mol. Pharmacol. 48 (1995) 98-104
70. Hollecker M., Marshall D.L., and Harvey A.L. Structural features important for the biological activity of the potassium channel blocking dendrotoxins. Br. J. Pharmacol. 110 (1993) 790-794
71. Hugues M., Duval D., Kitabi P., Lazdunski M., and Vincent J.P. Preparation of a pure monoiodo derivative of the bee venom neurotoxin apamin and its binding properties to rat brain synaptosomes. J. Biol. Chem. 257 (1982) 2762-2769
72. Hugues M., Duval D., Schmid H., Kitabgi P., and Lazdunski M. Specific binding and pharmacological interactions of apamin, the neurotoxin from bee venom, with guinea-pig colon. Life Sci. 31 (1982) 437-443
73. Hugues M., Schmid H., Romey G., Duval D., Frelin C., and Lazdunski M. Apamin as a selective blocker of the calcium dependent potassium channel in neuroblastoma cells: Voltage clamp and biochemical characterization of the toxin receptor. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 1308-1312
74. Hugues M., Schmid H., Romey G., Duval D., Frelin C., and Lazdunski M. The Ca2+-dependent slow K+ conductance in cultured rat muscle cells: Characterization with apamin. EMBO J. 1 (1982) 1039-1042
75. Hurst R.S., Busch A.E., Kavanaugh M.P., Osborne P.B., North R.A., and Adelman J.P. Identification of amino acid residues involved in dendrotoxin block of rat voltage-dependent potassium channels. Mol. Pharmacol. 40 (1991) 572-576
76. Inagaki N., Gonoi IV T., Namba J.P.C.N., Inazawa J., Gonzalez G., Aguilar-Bryan L., Seino S., and Bryan J. Reconstitution of IKatp: An inward rectifier subunit plus the sulfonylurea receptor. Science 270 (1995) 1166-1170
77. Johnson B.A., and Sugg E.E. Determination of the three-dimensional structure of iberiotoxin in solution by 1H nuclear magnetic resonance spectroscopy. Biochemistry 31 (1992) 8151-8159
78. Johnson B.A., Stevens S.P., and Williamson J.M. Determination of the three-dimensional structure of margatoxin by 1H, 13C, 15N triple-resonance nuclear magnetic resonance spectroscopy. Biochemistry 33 (1994) 15061-15070
79. Kaczorowski G.J., Knaus H.-G., Leonard R.J., McManus O.B., and Garcia M.L. High conductance calcium-activated potassium channels; structure, pharmacology and function. J. Biomembr. Bioenerg. 28 (1996) 253-265
80. Kau S.T., Zografos P., Do M.L., Halterman T.J., McConville M.W., Yochim C.L., Trivedi S., Howe B.B., and Li J.H.Y. Characterization of ATP-sensitive potassium channel-blocking activity of Zeneca ZM181,037, a eukalemic diuretic. Pharmacology 49 (1994) 238-248
81. Kavanaugh M.P., Hurst R.S., Yakel J., Varnum M.D., Adelman J.P., and North R.A. Multiple subunits of a voltage-dependent potassium channel contribute to the binding site for tetraethylammonium. Neuron 8 (1992) 493-497
82. Kiehn J., Wible B., Ficker E., Taglialatela M., and Brown A.M. Cloned human inward rectifier K+ channel as a target for class III methanesulfonanilides. Circ. Res. 77 (1995) 1151-1155
83. Kirsch G.E., Taglialatela M., and Brown A.M. Internal and external TEA block in single cloned K+ channels. Am. J. Physiol. 261 (1991) C583-C590
84. Kirsch G.E., Drewe J.A., Hartmann H.A., Taglialatela M., DeBiasi M., Brown A.M., and Joho R.H. Differences between the deep pores of K+ channels determined by an interacting pair of nonpolar amino acids. Neuron 8 (1992) 499-505
85. Kirsch G.E., Drewe J.A., Taglialatela M., Joho R.H., DeBiasi M., Hartman H.A., and Brown A.M. A single nonpolar residue in the deep pore of related K+ channels acts as K+:Rb+ conductance switch. Biophys. J. 62 (1992) 136-143
86. Kirsch G.E., Shieh C.C., Drewe J.A., Vener D.F., and Brown A.M. Segmental exchanges define 4-aminopyridine binding and the inner mouth of K+ pores. Neuron 11 (1993) 1-20
87. Knaus H.-G., Garcia-Calvo M., Kaczorowski G.J., and Garcia M.L. Subunit composition of the high conductance calcium-activated potassium channel from smooth muscle, a representative of the mSlo and slowpoke family of potassium channels. J. Biol. Chem. 269 (1994) 3921-3924
88. Knaus H.-G., Folander K., Garcia-Calvo M., Garcia M.L., Kaczorowski G.J., Smith M., and Swanson R. Primary sequence and immunological characterization of the β-subunit of the high-conductance Ca2+-activated K+ channel from smooth muscle. J. Biol. Chem. 269 (1994) 17274-17278
89. Knaus H.-G., Eberhart A., Kaczorowski G.J., and Garcia M.L. Covalent attachment of charybdotoxin to the β-subunit of the high-conductance Ca2+-activated K+ channel. J. Biol. Chem. 269 (1994) 23336-23341
90. Knaus H.-G., McManus O.B., Lee S.H., Schmalhofer W.A., Garcia-Calvo M., Helms L.M.H., Sanchez M., Giangiacomo K., Reuben J.P., Smith III A.B., Kaczorowski G.J., and Garcia M.L. Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance Ca2+-activated K+ channels. Biochemistry 33 (1994) 5819-5828
91. Knaus H.-G., Koch R.O.A., Eberhart A., Kaczorowski G.J., Garcia M.L., and Slaughter R.S. [125I]Margatoxin, an extraordinarily high affinity ligand for voltage-gated potassium channels in mammalian brain. Biochemistry 34 (1995) 13627-13634
92. Knaus H.-G., Schwarzer C., Koch R.O.A., Eberhart A., Kaczorowski G.J., Glossmann H., Wunder F., Pongs O., Garcia M.L., and Sperk G. Distribution of high-conductance Ca2+-activated K+ channels in rat brain: Targeting to axons and nerve terminals. J. Neurosci. 16 (1996) 955-963
93. Kohler M., Hirschberg B., Bond C.T., Kinzie J.M., Marrion N.V., Maylie J., and Adelman J.P. Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273 (1996) 1709-1714
94. Koo G.C., Blake J.T., Talento A., Nguyen M., Lin S., Sirotina A., Shah K., Mulvany K., Hora Jr. D., Cunningham P., Slaughter R., Bugianesi R., Felix J., Garcia M., Williamson J., Kaczorowski G., Sigal N., Springer M., and Feeney W. Marga-toxin, a blocker of Kv1.3 channels, inhibits immune responses in vivo. Fed. Proc., Fed. Am. Soc. Exp. Biol. 10 (1996) A 1447
95. Krezel A.M., Kasibhatla C., Hidalgo P., MacKinnon R., and Wagner G. Solution structure of the potassium channel inhibitor agitoxin 2: Caliper for probing channel geometry. Protein Sci. 4 (1995) 1478-1489
96. Lambert P., Kuroda H., Chino N., Watanabe T.X., Kimura T., and Sakakibara S. Solution synthesis of charybdotoxin (ChTX), a K+ channel blocker. Biochem. Biophys. Res. Commun. 170 (1990) 684-690
97. Laraba-Djebari F., Legros C., Crest M., Ceard B., Romi R., Mansuelle P., Jacquet G., von Rietschoten J., Gola M., Rochat H., Bougis P.E., and Martin-Eauclaire M.-F. The kaliotoxin family enlarged. J. Biol. Chem. 269 (1994) 32835-32843
98. Latorre R., Oberhauser A., Labarca P., and Alvarez O. Varieties of calcium-activated potassium channels. Annu. Rev. Physiol. 51 (1989) 385-399
99. Leonard R.J., Garcia M.L., Slaughter R.S., and Reuben J.P. Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: Mechanism of the antipro-liferative effect of charybdotoxin. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10094-10098
100. Leveque C., Marqueze B., Couraud F., and Seagar M. Polypeptide components of the apamin receptor associated with a calcium activated potassium channel. FEBS Lett. 275 (1990) 185-189
101. Lin C.S., Boltz R.C., Blake J.T., Nguyen M., Talento A., Fischer P.A., Springer M.S., Sigal N.H., Slaughter R.S., Garcia M.L., Kaczorowski G.J., and Koo G.C. Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J. Exp. Med. 177 (1993) 637-645
102. Lu Z., Lewis J.H., and MacKinnon R. Probing the pore of an inward-rectifier K+ channel with a scorpion toxin. Biophys. J. 70 (1996) 145a
103. Lucchesi K., Ravindran A., Young H., and Moczydlowski E. Analysis of the blocking activity of charybdotoxin homologs and iodinated derivatives against Ca2+-activated K+ channels. J. Membr. Biol. 109 (1989) 269-281
104. MacKinnon R., and Miller C. Mechanism of charybdotoxin block of the high-conductance, Ca2+-activated K+ channel. J. Gen. Physiol. 91 (1988) 335-349
105. MacKinnon R., and Miller C. Functional modification of a Ca2+-activated K+ channel by trimethyloxonium. Biochemistry 28 (1989) 8087-8092
106. MacKinnon R., and Yellen G. Mutations affecting TEA blockade and ion permeation in voltage-activated K+ channels. Science 250 (1990) 276-279
107. MacKinnon R., Reinhart P.H., and White M.M. Charybdotoxin block of Shaker K+ channels suggests that different types of K+ channels share common structural features. Neuron 1 (1988) 997-1001
108. Majumder K., Biasi M.D., Wang Z., and Wible B.A. Molecular cloning and functional expression of a novel potassium channel β-subunit from human atrium. FEBS Lett. 361 (1995) 13-16
109. Martin B.M., Ramirez A.N., Gurrola G.B., Nobile M., Prestipino G., and Possani L.D. Novel K+-channel-blocking toxins from the venom of the scorpion Centruroides litnpidus limpidus Karsch. Biochem. J. 304 (1994) 51-56
110. Martins J.C., Van de Ven F.J.M., and Borremans F.A.M. Determination of the three-dimensional solution structure of scyllatoxin by 1H nuclear magnetic resonance. J. Mol. Biol. 253 (1995) 590-603
111. McCormack K., McCormack T., Tanouye M., Rudy B., and Stühmer W. Alternative splicing of the human Shaker K+ channel β1 gene and functional expression of the β2 gene product. FEBS Lett. 370 (1995) 32-36
112. McCullough J.R., Normandin D.E., Conder M.L., Sleph P.G., Dzwonczyk S., and Grover G.J. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ. Res. 69 (1991) 949-958
113. McManus O.B. Calcium-activated potassium channels: Regulation by calcium. J. Bioenerg. Biomembr. 23 (1991) 537-560
114. McManus O.B., Harris G.H., Giangiacomo K.M., Feigenbaum P., Reuben J.P., Addy M.E., Burka J.F., Kaczorowski G.J., and Garcia M.L. An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry 32 (1993) 6128-6133
115. McManus O.B., Helms L.M.H., Pallanck L., Ganetzky B., Swanson R., and Leonard R.J. Functional role of the β subunit of high-conductance calcium-activated potassium channels. Neuron 14 (1995) 1-20
116. Michne W.F., Miles J.W., Treasurywala A.M., Castonguay L.A., Weigelt C., Oconnor B., Volberg W.A., Grant A.M., Chadwick C.C., Kraft D.S., and Hill R.J. Novel inhibitors of potassium ion channels on human T lymphocytes. J. Med. Chem. 38 (1995) 1877-1883
117. Miller C., Moczydlowski E., Latorre R., and Phillips M. Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle. Nature (London) 313 (1985) 316-318
118. Morales M.J., Castellino R.C., Crews A.L., Rasmusson R.L., and Strauss H.C. A novel β subunit increases rate of inactivation of specific voltage-gated potassium channel α subunits. J. Biol. Chem. 270 (1995) 6272-6277
119. Muniz Z.M., Parcej D.N., and Dolly J.O. Characterization of monoclonal antibodies against voltage-dependent K+ channels raised using α-dendrotoxin acceptors purified from bovine brain. Biochemistry 31 (1992) 12297-12303
120. Nguyen A., Kath J., Hanson D., Dethlefs B., Gutman G., Cahalan M.D., and Chandy K.G. A novel class of potent organic blockers of the T-cell K channel, Kvl.3, that are selective for histidine 404. Biophys. J. 70 (1996) A446
121. Novick J., Leonard R.J., King V.F., Schmalhofer W., Kaczorowski G.J., and Garcia M.L. Purification and characterization of two novel peptidyl toxins directed against K+ channels from venom of new world scorpions. Biophys. J. 59 (1991) 78a
122. Olesen S.-P. Activators of large-conductance Ca2+-dependent K+ channels. Exp. Opin. Invest. Drugs 3 (1994) 1181-1188
123. Olesen S.-P., Munch E., Moldt P., and Drejer J. Selective activation of Ca2+-dependent K+ channels by novel benzimidazolone. Eur. J. Pharmacol. 251 (1994) 53-59
124. Olesen S.-P., Mathiasen D., Christophersen P., Ahring P.K., and Johansen T.E. The substituted diphenylurea NS 1608 activates the α-subunit of the human BK channel (hSlo). Biophys. J. 70 (1996) 129a
125. Pallanck L., and Ganetzky B. Cloning and characterization of human and mouse homologs of the Drosophila calcium-activated potassium channel gene, slowpoke. Hum. Mol. Genet. 3 (1994) 1239-1243
126. Parcej D.N., and Dolly J.O. Dendrotoxin acceptor from bovine synaptic plasma membranes: Binding properties, purification and subunit composition of a putative constituent of certain voltage-activated K+ channels. Biochem. J. 257 (1989) 899-903
127. Park C.-S., and Miller C. Interaction of charybdotoxin with permeant ions inside the pore of a K+ channel. Neuron 9 (1992) 307-313
128. Park C.-S., Hausdorff S.F., and Miller C. Design, synthesis and functional expression of a gene for charybdotoxin, a peptide blocker of K+ channels. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2046-2050
129. Pease J.H.B., and Wemmer D.E. Solution structure of apamin determined by nuclear magnetic resonance and distance geometry. Biochemistry 27 (1988) 8491-8498
130. Penner R., Petersen M., Pierau F.-K., and Dreyer F. Dendrotoxin: a selective blocker of a non-inactivating potassium current in guinea pig dorsal root ganglion neurons. Pflüeger's Arch. 407 (1986) 365-369
131. Pennington M.W., Byrnes M.E., Zaydenberg I., Khaytin I., Chastonay J.D., Krafte D.S., Hill R., Mahnir V.M., Volberg W.A., Gorczyca W., and Kern W.R. Chemical synthesis and characterization of ShK toxin: A potent potassium channel inhibitor from a sea anemone. Int. J. Pept. Protein Res. 46 (1995) 354-358
132. Pennington M.W., Mahnir V.M., Krafte D.S., Zaydenberg I., Byrnes M.E., Khaytin I., Crowley K., and Kem W.R. Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocyte and rat brain. Biochem. Biophys. Res. Commun. 219 (1996) 696-701
133. Pongs O. Regulation of the activity of voltage-gated potassium channels by β subunits. Semin. Neurosci. 7 (1995) 137-146
134. Possani L.D., Martin B.M., and Svendsen I.B. The primary structure of Noxiustoxin: A K+ channel blocking peptide, purified from the venom of the scorpion Centruroides noxius Hoffmann. Carlsberg Res. Commun. 47 (1982) 285-289
135. Quast U., and Cook N.S. In vitro and in vivo comparison of two K+ channel openers diazoxide and cromakalim and their inhibition by glibenclamide. J. Pharmacol. Exp. Ther. 250 (1989) 261-271
136. Rehm H., and Lazdunski M. Existence of different populations of the dendrotoxin I binding protein associated with neuronal K+ channels. Biochem. Biophys. Res. Commun. 153 (1988) 231-240
137. Rehm H., and Lazdunski M. Purification and subunit structure of a putative K+-channel protein identified by its binding properties for dendrotoxin I. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 4919-4923
138. Rehm H., Bidard J.-N., Schweitz H., and Lazdunski M. The receptor site for bee venom mast cell degranulating peptide. Affinity labeling and evidence for a common target for mast cell degranulating peptide and dendrotoxin I, a snake toxin active on K+ channels. Biochemistry 27 (1988) 1827-1832
139. Rehm H., Pelzer S., Cochet C., Chambaz E., Temple B.L., Trautwein W., Pelzer D., and Lazdunski M. Dendrotoxin-binding brain membrane protein displays a K+ channel activity that is stimulated by both cAMP-dependent and endogenous phosphorylations. Biochemistry 28 (1989) 6455-6460
140. Rettig J., Heinemann S.H., Wunder F., Lorra C., Parcej D.N., Dolly J.O., and Pongs O. Inactivation properties of voltage-gated K+ channels altered by presence of β-subunit. Nature (London) 369 (1994) 289-294
141. Rogowski R.S., Krueger B.K., Collins J.H., and Blaustein M.P. Tityustoxin Kα blocks voltage-gated noninactivating K+ channels and unblocks inactivating K+ channels blocked by a-dendrotoxin in synaptosomes. Proc. Natl. Acad. Aci. U.S.A. 91 (1994) 1475-1479
142. Romey G., Hugues M., Schmid-Antomarchi H., and Lazdunski M. Apamin: a specific toxin to study a class of Ca2+-dependent K+ channels. J. Physiol. (Paris) 79 (1984) 259-264
143. Romi R., Crest M., Gola M., Sampieri F., Jacquet G., Zerrouk H., Mansuelle P., Sorokine O., Dorsselaer A.V., Rochat H., Martin-Eauclaire M.-F., and Rietschoten J.V. Synthesis and characterization of kaliotoxin. J. Biol. Chem. 268 (1993) 26302-26309
144. Sabatier J.-M., Zerrouk H., Darbon H., Mabrouk K., Benslimane A., Rochat H., Martin-Eauclaire M.-F., and Rietschoten J.V. P05, a new leiurotoxin I-like scorpion toxin: Synthesis and structure-activity relationships of the α-amidated analog, a ligand of Ca2+-activated K+ channels with increased affinity. Biochemistry 32 (1993) 2763-2770
145. Sabatier J.-M., Fremont V., Mabrouk K., Crest M., Darbon H., Rochat H., Rietschoten J.V., and Martin-Eauclaire M.-F. Leiurotoxin I, a scorpion toxin specific for Ca2+-activated K+ channels: Structure-activity analysis using synthetic analogs. Int. J. Pept. Protein Res. 43 (1994) 486-495
146. Sakura H., Ämmälä C., Smith P.A., Gribble F.M., and Ashcroft F.M. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett. 377 (1995) 338-344
147. Sands S.B., Lewis R.S., and Cahalan M.D. Charybdotoxin blocks, voltage-gated K+ channels in human and murine T lymphocytes. J. Gen. Physiol. 93 (1989) 1061-1074
148. Sanguinetti M.C., Curran M.E., Spector P.S., and Keating M.T. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2208-2212
149. Sanguinetti M.C., Curran M.E., Zou A., Shen J., Spector P.S., Atkinson D.L., and Keating M.T. Coassembly of KVLQT1 andminK (IsK) proteins to form cardiac Iks, potassium channel. Nature 384 (1996) 80-83
150. Sasaki Y., Ishii K., Nunoki K., Yamagishi T., and Taira N. The voltage-dependent K+ channel (Kv1.5) cloned from rabbit heart and facilitation of inactivation of the delayed rectifier current by the rat β subunit. FEBS Lett. 372 (1995) 20-24
151. Schmid-Antomarchi H., Renaud J.F., Romey G., Hugues M., Schmid A., and Lazdunski M. The all-or-none role of innervation in expression of
152. Schmid-Antomarchi H., Hugues M., and Lazdunski M. Properties of the apamin-sensitive Ca2+-activated K+ channel in PC12 pheochromocytoma cells which hyper-produce the apamin receptor. J. Biol. Chetn. 261 (1986) 8633-8637
153. Schweitz H., Bidard J.-N., and Lazdunski M. Purification and pharmacological characterization of peptide toxins from the black mamba (Dendroaspis polylepis) venom. Toxicon 28 (1990) 847-856
154. Schweitz H., Bruhn T., Guillemare E., Moinier D., Lancelin J.-M., Béress L., and Lazdunski M. Kalicludines and kaliseptine. Two different classes of sea anemone toxins for voltage-sensitive K+ channels. J. Biol. Chem. 270 (1995) 25121-25126
155. Scott V.E.S., Parcej D.N., Keen J.N., Keen J.B.C., and Dolly J.O. α-Dendrotoxin acceptor from bovine brain is a K+ channel protein. J. Biol. Chem. 265 (1990) 20094-20097
156. Scott V.E.S., Muniz Z.M., Sewing S., Lichtinghagen R., Parcej D.N., Pongs O., and Dolly J.O. Antibodies specific for distinct Kv subunits unveil a heterooligomeric basis for subtypes of α-dendrotoxin-sensitive K+ channels in bovine brain. Biochemistry 33 (1994) 1617-1623
157. Scott V.E.S., Rettig J., Parcej D.N., Keen J.N., Findlay J.B.C., Pongs O., and Dolly J.O. Primary structure of a β subunit of α-dendrotoxin-sensitive K+ channels from bovine brain. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1637-1641
158. Seagar M.J., Granier C., and Couraud F. Interactions of the neurotoxin apamin with a Ca++ activated K+ channel in primary cultured neurons. J. Biol. Chem. 259 (1984) 1491-1495
159. Seagar M.J., Labbe-Jullie C., Granier C., Goll A., Glossmann H., Rietschoten J.V., and Couraud F. Molecular structure of rat brain apamin receptor: differential photoaffinity labelling of putative K+ channel subunits and target size analysis. Biochemistry 25 (1986) 4051-4057
160. Shimony E., Sun T., Kolmakova-Partensky L., and Miller C. Engineering a uniquely reactive thiol into a cysteine-rich peptide. Protein Eng. 7 (1994) 503-507
161. Singh S.B., Goetz M.A., Zink D.L., Dombrowski A.W., Polishook J.D., Garcia M.L., Schmalhofer W., McManus O.B., and Kaczorowski G.J. MaxiKdiol: A novel dihydroxyisoprimane as an agonist of maxi-K channels. J. Chem. Soc., Perkin Trans. 1 (1994) 3349-3352
162. Sitges M., Possani L.D., and Bayón A. Noxiustoxin, a short-chain toxin from the Mexican scorpion CSentruroides noxius, induces transmitter release by blocking K+ permeability. J. Neurosci. 6 (1986) 1570-1574
163. Skarzynski T. Crystal structure of a-dendrotoxin from the green mamba venom and its comparison with the structure of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 224 (1992) 671-683
164. Slaughter R.S., Shevell J.L., Felix J.P., Lin C.S., Sigal N.H., and Kaczorowski G.J. Inhibition by toxins of charybdotoxin binding to the voltage-gated potassium channel of lymphocytes: Correlation with block of activation of human peripheral T-lymphocytes. Biophys. J. 59 (1991) 213a
165. Smith C., Phillips M., and Miller C. Charybdotoxin, a specific inhibitor of the high conductance Ca2+-activated K+ channel. J. Biol. Chem. 261 (1986) 14607-14613
166. Smith L.A., Olson M.A., Lafaye P.J., and Dolly J.O. Cloning and expression of mamba toxins. Toxicon 33 (1995) 459-474
167. Sorensen R.G., and Blaustein M.P. Rat brain dendrotoxin receptors associated with voltage-gated potassium channels: Dendrotoxin binding and receptor solubilization. Mol. Pharmacol. 36 (1989) 689-698
168. Spector P.S., Curran M.E., Keating M.T., and Sanguinetti M.C. Class III antiar-rhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Circ. Res. 78 (1996) 499-503
169. Stampe P., Kolmakova-Partensky L., and Miller C. Intimations of K+ channel structure from a complete functional map of the molecular surface of charybdotoxin. Biochemistry 33 (1994) 443-450
170. Stansfeld C.E., Marsh S.J., Halliwell J.V., and Brown D.A. 4-Aminopyridine and dendrotoxin induce repetitive firing in rat visceral sensory neurones by blocking a slowly inactivating outward current. Neurosci. Lett. 64 (1986) 299-304
171. Stephens G.J., Cockett M.I., Nawoschik S.P., Schecter L.E., and Owen D.G. The modulation of the rate of inactivation of the mKv1.1 K+ channel by the β subunit, Kvβ1 and lack of effect of a Kvβ1 N-terminal peptide. FEBS Lett. 378 (1996) 250-252
172. Stocker M., and Miller C. Electrostatic distance geometry in a K+ channel vestibule. Proc. Natl. Acad. Set. U.S.A. 91 (1994) 9509-9513
173. Sugg E.E., Garcia M.L., Reuben J.P., Patchett A.A., and Kaczorowski G.J. Synthesis and structural characterization of charybdotoxin, a potent peptidyl inhibitor of the high conductance Ca2+-activated K+ channel. J. Biol. Chem. 265 (1990) 18745-18748
174. Sun T., Naini A.A., and Miller C. High-level expression and functional reconstitution of Shaker K+ channels. Biochemistry 33 (1994) 9992-9999
175. Swanson R., Marshall J., Smith J.S., Williams J.B., Boyle M.B., Folander K., Luneau C.J., Antanavage J., Oliva C., Buhrow S.A., Bennett C., Stein R.B., and Kaczmarek L.K. Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brian. Neuron 4 (1990) 929-939
176. Swartz K.J., and MacKinnon R. An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantula. Neuron 15 (1995) 941-949
177. Taglialatela M., VanDongen A.M.J., Drewe J.A., Joho R.H., Brown A.M., and Kirsch G.E. Patterns of internal and external tetraethylammonium block in four homologous K+ channels. Mol. Pharmacol. 40 (1991) 299-307
178. Tseng-Crank J., Foster C.D., Krause J.D., Mertz R., Godinot N., DiChiara T.J., and Reinhart P.H. Cloning, expression and distribution of functionally distinct Ca2+-activated K+ channel isoforms from human brain. Neuron 13 (1994) 1315-1330
179. Tytgat J., Debont T., Carmeliet E., and Daenens P. The α-dendrotoxin footprint on a mammalian potassium channel. J. Biol. Chem. 270 (1995) 24776-24781
180. Uebele V.N., England S.K., Chaudhary A., Tamkun M.M., and Snyders D.J. Functional differences in Kv1.5 currents expressed in mammalian cell lines are due to the presence of endogenous Kvβ2.1 subunits. J. Biol. Chem. 271 (1996) 2406-2412
181. Vazquez J., Feigenbaum P., Katz G., King V.F., Reuben J.P., Roy-Contancin L., Slaughter R.S., Kaczorowski G.J., and Garcia M.L. Characterization of high affinity binding sites for charybdotoxin in sarcolemmal membranes from bovine aortic smooth muscle: Evidence for a direct association with the high conductance calcium-activated potassium channel. J. Biol. Chem. 264 (1989) 20902-20909
182. Vazquez J., Feigenbaum P., King V.F., Kaczorowski G.J., and Garcia M.L. Characterization of high affinity binding sites for charybdotoxin in synaptic plasma membranes from rat brain: Evidence for a direct association with an inactivating, voltage-dependent, potassium channel. J. Biol. Chem. 256 (1990) 15564-15571
183. Wallner M., Meera P., Ottolia M., Kaczorowski G.J., Latorre R., Garcia M.L., Stefani E., and Toro L. Characterization of and modulation by a β-subunit of a human maxi KCa channel cloned from myometrium. Recept. Channels 3 (1995) 185-199
184. Ward J.P.T., Taylor S.G., and Collier M.L. The novel benzopyranol potassium channel activator BRL55834 activates two potassium channels in bovine airway smooth muscle. Br. J. Pharmacol. 107 (1992) 49P
185. Wei A., Solaro C., Lingle C., and Salkoff L. Calcum sensitivity of BK-type KCa channels determined by a separable domain. Neuron 13 (1994) 671-681
186. Werkman T.R., Kawamura T., Yokoyama S., Higashida H., and Rogawski M.A. Charybdotoxin, dendrotoxin and mast cell degranulating peptide block the voltage-activated K+ current of fibroblast cells stably transfected with NGK1 (Kv1.2) K+ channel complementary DNA. Neuroscience 4 (1992) 935-946
187. Yellen G., Jurman M.E., Abramson T., and MacKinnon R. Mutations affecting internal TEA blockade identify the probable pore-forming region of a K+ channel. Science 251 (1991) 939-942
188. Zünkler B.J., Lenzen S., Mauer K., Panten U., and Trube G. Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic β-cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 337 (1988) 225-230